| abstract |
The present invention relates to prodrug derivatives of 5-chloro-N-({(5S)-3-[2-fluoro-4-(3- oxomopholin-4-yl)phenyl]-2-oxo-l,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of disorders, and to the use thereof for production of medicaments for treatment and/or prophylaxis of disorders, especially of thromboembolic disorders. |